Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

143

currently held

Exits tracked

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-09-23

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks ago

Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Lauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month ago

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
Nucleome Therapeutics Oxford Science Enterprises Balance Sheet	Biotech	UK	Oxford Science Enterprises	2019	7yr	Active	–	–
Nuntius Therapeutics Backed Fund II	Biotech	UK	BACKED VC	2021	5yr	Active	–	–
Ochre-Bio Backed Fund II	Biotech	UK	BACKED VC	2020	6yr	Active	–	–
OMass Therapeutics Oxford Science Enterprises Balance Sheet	Biotech	UK	Oxford Science Enterprises	2016	10yr	Active	–	–
Orbit Discovery Oxford Science Enterprises Balance Sheet	Biotech	UK	Oxford Science Enterprises	2016	10yr	Active	–	–
Ori Biotech Amadeus IV Digital Prosperity Fund	Biotech	UK	Amadeus Capital Partners	2020	6yr	Active	–	–
PharmEnable Parkwalk Opportunities EIS Fund	Biotech	UK	Parkwalk Advisors	2020	6yr	Active	–	–
Pheno Therapeutics LifeArc Ventures	Biotech	UK	LifeArc	2020	6yr	Active	–	–
Qkine Parkwalk Opportunities EIS Fund	Biotech	UK	Parkwalk Advisors	2020	6yr	Active	–	–
Reacta Healthcare Development Bank of Wales (Balance Sheet)	Biotech	UK	Development Bank of Wales	2019	7yr	Active	–	–
ReNeuron Rosetta Capital V	Biotech	UK	Rosetta Capital	2021	5yr	Active	–	–
Resolution Therapeutics Old College Capital LP	Biotech	UK	Old College Capital	2020	6yr	Active	–	–
Sano Genetics MMC Ventures EIS Fund	Biotech	UK	MMC Ventures	2022	4yr	Active	–	–
Semarion Parkwalk Opportunities EIS Fund	Biotech	UK	Parkwalk Advisors	2022	4yr	Active	–	–
SignaCor QUBIS Ltd	Biotech	UK	Qubis	2024	2yr	Active	–	–
Sitryx Oxford Science Enterprises Balance Sheet	Biotech	UK	Oxford Science Enterprises	2023	3yr	Active	–	–
SpyBiotech Oxford Science Enterprises Balance Sheet	Biotech	UK	Oxford Science Enterprises	2017	9yr	Active	–	–
STORM Therapeutics CIC Fund I	Biotech	UK	Cambridge Innovation Capital	2016	10yr	Active	–	–
T-Cypher Bio Oxford Science Enterprises Balance Sheet	Biotech	UK	Oxford Science Enterprises	2021	5yr	Active	–	–
Ten63 Therapeutics RYSE Special Opportunities Fund	Biotech	UK	Ryse Asset Management	2026	0yr	Active	–	–
Theolytics Oxford Science Enterprises Balance Sheet	Biotech	UK	Oxford Science Enterprises	2017	9yr	Active	–	–
Tozaro Mercia Direct Investments	Biotech	UK	Mercia Asset Management	2015	11yr	Active	–	–
Univ8 Genomics QUBIS Ltd	Biotech	UK	Qubis	2019	7yr	Active	–	–
Vantage Biosciences ALSA Ventures European Biotechnology Fund	Biotech	UK	ALSA Ventures	2023	3yr	Active	–	–
Vascversa Ltd QUBIS Ltd	Biotech	UK	Qubis	2019	7yr	Active	–	–
ViaNautis Bio 4BIO Ventures III	Biotech	UK	4Bio Partners	2023	3yr	Active	–	–
Zentraxa Elbow Beach Capital	Biotech	UK	Elbow Beach Investments	2022	4yr	Active	–	–
Imperagen2 periods IQ Capital Fund IV	Biotech	UK	IQ Capital Partners	2022	4yr	Active	–	–
IMU Biosciences2 periods IQ Capital Fund IV	Biotech	UK	IQ Capital Partners	2024	2yr	Active	–	–
Monument Therapeutics2 periods Angel CoFund	Biotech	UK	ACF Investors	2024	2yr	Active	–	–
NRG Therapeutics2 periods Criteria Bio Ventures	Biotech	UK	Caixa Capital Risc	2020	6yr	Active	–	–
Oxford Biomedica2 periods Vitruvian Investment Partnership IV	Biotech	UK	Vitruvian Partners	2019	7yr	Active	–	–
RQ Biotechnology2 periods LifeArc Ventures	Biotech	UK	LifeArc	2022	4yr	Active	–	–
Scripta Therapeutics2 periods Apollo Health Ventures Fund II	Biotech	UK	Apollo Health Ventures	2025	1yr	Active	–	–
Alethio Therapeutics Oxford Science Enterprises Balance Sheet	Biotech	UK	Oxford Science Enterprises	2025	1yr	Active	–	–
Apini Therapeutics Northern Gritstone Evergreen	Biotech	UK	Northern Gritstone	2025	1yr	Active	–	–
Apollo Therapeutics IP Group (Evergreen)	Biotech	UK	IP Group	2017	9yr	Active	–	–
Btxa Nanotherapy Ltd QUBIS Ltd	Biotech	UK	Qubis	2022	4yr	Active	–	–
Cagen UK Innovation and Science Seed Fund	Biotech	UK	Future Planet Capital	2018	8yr	Active	–	–
CAM GenetiX UK Innovation and Science Seed Fund	Biotech	UK	Future Planet Capital	2025	1yr	Active	–	–
Cetromed EMV Capital Evergreen Fund	Biotech	UK	EMV Capital	2021	5yr	Active	–	–
Circadian Therapeutics Oxford Science Enterprises Balance Sheet	Biotech	UK	Oxford Science Enterprises	2016	10yr	Active	–	–
Corryn Biotechnologies Development Bank of Wales (Balance Sheet)	Biotech	UK	Development Bank of Wales	2026	0yr	Active	–	–
Cyclana Bio Eka Ventures Fund II	Biotech	UK	EKA Ventures	2025	1yr	Active	–	–
CytoSeek UK Innovation and Science Seed Fund	Biotech	UK	Future Planet Capital	2019	7yr	Active	–	–
DaltonTx IQ Capital Fund IV	Biotech	UK	IQ Capital Partners	2025	1yr	Active	–	–
Evonetix Molten Ventures Balance Sheet	Biotech	UK	Molten Ventures	2018	8yr	Active	–	–
ExpressionEdits BlueYard Capital Fund III	Biotech	UK	BlueYard Capital	2024	2yr	Active	–	–
GeneratR QUBIS Ltd	Biotech	UK	Qubis	2022	4yr	Active	–	–
Gran Lab Ltd QUBIS Ltd	Biotech	UK	Qubis	2024	2yr	Active	–	–

Portfolio companies.34,000+ PE-backed.

Portfolio companies.
34,000+ PE-backed.